{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:11:53Z","timestamp":1790190713830,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Saint Louis University Department of Pediatrics in association with the Fleur de Lis Organization and the Cardinal Glennon Foundation"},{"DOI":"10.13039\/100016853","name":"Lysosomal Disease Network","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016853","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Mucopolysaccharidosis IVA (Morquio A syndrome) is a lysosomal storage disease caused by the deficiency of enzyme\n                      <jats:italic>N<\/jats:italic>\n                      -acetylgalactosamine-6-sulfate sulfatase (GALNS), which results in the accumulation of the glycosaminoglycans (GAGs), keratan sulfate, and chondroitin-6-sulfate in the lysosomes of all tissues causing systemic dysfunction. Current treatments include enzyme replacement therapy (ERT) which can treat only certain aspects of the disease such as endurance-related biological endpoints. A key challenge in ERT is ineffective enzyme uptake in avascular tissues, which makes the treatment of the corneal, cartilage, and heart valvular tissue difficult. The aim of this study was to culture human umbilical mesenchymal stem cells (UMSC), demonstrate presence of GALNS enzyme activity within the extracellular vesicles (EVs) derived from these UMSC, and study how these secreted EVs are taken up by GALNS-deficient cells and used by the deficient cell\u2019s lysosomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We obtained and cultured UMSC from the umbilical cord tissue from anonymous donors from the Saint Louis Cord Blood Bank. We characterized UMSC cell surface markers to confirm phenotype by cell sorting analyses. In addition, we confirmed that UMSC secrete GALNS enzyme creating conditioned media for co-culture experiments with GALNS deficient cells. Lastly, we isolated EVs derived from UMSC by ultracentrifugation to confirm source of GALNS enzyme.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Co-culture and confocal microscopy experiments indicated that the lysosomal content from UMSC migrated to deficient cells as evidenced by the peak signal intensity occurring at 15 min. EVs released by UMSC were characterized indicating that the EVs contained the active GALNS enzyme. Uptake of GALNS within EVs by deficient fibroblasts was not affected by mannose-6-phosphate (M6P) inhibition, suggesting that EV uptake by these fibroblasts is gradual and might be mediated by a different means than the M6P receptor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>UMSC can deliver EVs containing functional GALNS enzyme to deficient cells. This enzyme delivery method, which was unaffected by M6P inhibition, can function as a novel technique for reducing GAG accumulation in cells in avascular tissues, thereby providing a potential treatment option for Morquio A syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-021-02355-0","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T07:02:42Z","timestamp":1620284562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Umbilical mesenchymal stem cell-derived extracellular vesicles as enzyme delivery vehicle to treat Morquio A fibroblasts"],"prefix":"10.1186","volume":"12","author":[{"given":"Michael","family":"Flanagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Emnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem","family":"Akel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-5789","authenticated-orcid":false,"given":"Adriana M.","family":"Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"issue":"1","key":"2355_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ymgme.2007.01.004","volume":"91","author":"S Tomatsu","year":"2007","unstructured":"Tomatsu S, Monta\u00f1o AM, Gutierrez M, Grubb JH, Oikawa H, Dung VC, et al. Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase. Mol Genet Metab. 2007;91(1):69\u201378.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2355_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/138920111795542615","volume":"12","author":"S Tomatsu","year":"2011","unstructured":"Tomatsu S, Monta\u00f1o AM, Oikawa H, Smith M, Barrera L, Chinen Y, et al. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol. 2011;12(6):931\u201345. https:\/\/doi.org\/10.2174\/138920111795542615.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"2355_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13023-020-1331-y","volume":"15","author":"RY Wang","year":"2020","unstructured":"Wang RY, Rudser KD, Dengel DR, Evanoff N, Steinberger J, Movsesyan N, et al. Abnormally increased carotid intima media-thickness and elasticity in patients with Morquio A disease. Orphanet J Rare Dis. 2020;15(1):73. https:\/\/doi.org\/10.1186\/s13023-020-1331-y.","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"2355_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2011.01.034","volume":"216","author":"A Berni","year":"2011","unstructured":"Berni A, Giuliani A, Tartaglia F, Tromba L, Sgueglia M, Blasi S, et al. Effect of vascular risk factors on increase in carotid and femoral intima-media thickness. Identification of a risk scale. Atherosclerosis. 2011;216(1):109\u201314. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.01.034.","journal-title":"Atherosclerosis."},{"issue":"2","key":"2355_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/RRED.S37278","volume":"2012","author":"S Tomatsu","year":"2012","unstructured":"Tomatsu S, Mackenzie WG, Theroux MC, Mason RW, Thacker MM, Shaffer TH, et al. Current and emerging treatments and surgical interventions for Morquio A syndrome: a review. Res Rep Endocr Disord. 2012;2012(2):65\u201377. https:\/\/doi.org\/10.2147\/RRED.S37278.","journal-title":"Res Rep Endocr Disord."},{"issue":"3","key":"2355_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymgme.2013.04.009","volume":"109","author":"E Yasuda","year":"2013","unstructured":"Yasuda E, Fushimi K, Suzuki Y, Shimizu K, Takami T, Zustin J, et al. Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder. Mol Genet Metab. 2013;109(3):301\u201311. https:\/\/doi.org\/10.1016\/j.ymgme.2013.04.009.","journal-title":"Mol Genet Metab."},{"issue":"3","key":"2355_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF01799267","volume":"19","author":"H Northover","year":"1996","unstructured":"Northover H, Cowie RA, Wraith JE. Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. J Inherit Metab Dis. 1996;19(3):357\u201365. https:\/\/doi.org\/10.1007\/BF01799267.","journal-title":"J Inherit Metab Dis."},{"issue":"5","key":"2355_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s10545-007-0702-z","volume":"30","author":"AM Monta\u00f1o","year":"2007","unstructured":"Monta\u00f1o AM, Sukegawa K, Kato Z, Carrozzo R, Di Natale P, Christensen E, et al. Effect of \u2018attenuated\u2019 mutations in mucopolysaccharidosis IVA on molecular phenotypes of N-acetylgalactosamine-6-sulfate sulfatase. J Inherit Metab Dis. 2007;30(5):758\u201367. https:\/\/doi.org\/10.1007\/s10545-007-0702-z.","journal-title":"J Inherit Metab Dis."},{"issue":"2","key":"2355_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00439-003-0959-8","volume":"113","author":"AM Monta\u00f1o","year":"2003","unstructured":"Monta\u00f1o AM, Kaitila I, Sukegawa K, Tomatsu S, Kato Z, Nakamura H, et al. Mucopolysaccharidosis IVA: characterization of a common mutation found in Finnish patients with attenuated phenotype. Hum Genet. 2003;113(2):162\u20139. https:\/\/doi.org\/10.1007\/s00439-003-0959-8.","journal-title":"Hum Genet."},{"issue":"12","key":"2355_CR10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nrg963","volume":"3","author":"RJ Desnick","year":"2002","unstructured":"Desnick RJ, Schuchman EH. Enzyme replacement and enhancement therapies: lessons from lysosomal disorders. Nat Rev Genet. 2002;3(12):954\u201366. https:\/\/doi.org\/10.1038\/nrg963.","journal-title":"Nat Rev Genet."},{"issue":"6","key":"2355_CR11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40265-014-0210-z","volume":"74","author":"M Sanford","year":"2014","unstructured":"Sanford M, Lo JH. Elosulfase alfa: first global approval. Drugs. 2014;74(6):713\u20138. https:\/\/doi.org\/10.1007\/s40265-014-0210-z.","journal-title":"Drugs."},{"issue":"4","key":"2355_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ymgme.2018.02.011","volume":"123","author":"C Hendriksz","year":"2018","unstructured":"Hendriksz C, Santra S, Jones SA, Geberhiwot T, Jesaitis L, Long B, et al. Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002\/MOR-100), representing 5years of treatment. Mol Genet Metab. 2018;123(4):479\u201387. https:\/\/doi.org\/10.1016\/j.ymgme.2018.02.011.","journal-title":"Mol Genet Metab."},{"key":"2355_CR13","unstructured":"A Study to Evaluate the Safety, Tolerability and efficacy of BMN 110 in subjects with mucopolysaccharidosis IVA: ClinicalTrials.gov. 2009.; 2009 [Available from: https:\/\/ClinicalTrials.gov\/show\/NCT00884949.\u00a0Accessed 20 Dec 2020."},{"issue":"1","key":"2355_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","volume":"109","author":"P Harmatz","year":"2013","unstructured":"Harmatz P, Mengel KE, Giugliani R, Valayannopoulos V, Lin SP, Parini R, et al. The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab. 2013;109(1):54\u201361. https:\/\/doi.org\/10.1016\/j.ymgme.2013.01.021.","journal-title":"Mol Genet Metab."},{"issue":"4","key":"2355_CR15","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jaip.2017.02.020","volume":"5","author":"H Guvenir","year":"2017","unstructured":"Guvenir H, Dibek Misirlioglu E, Capanoglu M, Buyuktiryaki B, Unal O, Toyran M, et al. Successful desensitization of elosulfase alfa-induced anaphylaxis in a pediatric patient with Morquio syndrome. J Allergy Clin Immunol Pract. 2017;5(4):1156\u20137. https:\/\/doi.org\/10.1016\/j.jaip.2017.02.020.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"2355_CR16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1172\/JCI125607","volume":"130","author":"AC Sosa","year":"2020","unstructured":"Sosa AC, Kariuki B, Gan Q, Knutsen AP, Bellone CJ, Guzman MA, et al. Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome. J Clin Invest. 2020;130(3):1288\u2013300. https:\/\/doi.org\/10.1172\/JCI125607.","journal-title":"J Clin Invest."},{"issue":"11","key":"2355_CR17","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","volume":"3","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Sawamoto K, Shimada T, Bober MB, Kubaski F, Yasuda E, et al. Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opin Orphan Drugs. 2015;3(11):1279\u201390. https:\/\/doi.org\/10.1517\/21678707.2015.1086640.","journal-title":"Expert Opin Orphan Drugs."},{"issue":"9","key":"2355_CR18","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/21678707.2017.1366900","volume":"5","author":"Y Puckett","year":"2017","unstructured":"Puckett Y, Mulinder H, Monta\u00f1o AM. enzyme replacement therapy with elosulfase alfa for mucopolysaccharidosis IVA (Morquio A Syndrome): milestones and challenges. Expert Opinion Orphan Drugs. 2017;5(9):741\u201352. https:\/\/doi.org\/10.1080\/21678707.2017.1366900.","journal-title":"Expert Opinion Orphan Drugs."},{"issue":"6","key":"2355_CR19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/hmg\/ddm353","volume":"17","author":"S Tomatsu","year":"2008","unstructured":"Tomatsu S, Monta\u00f1o AM, Ohashi A, Gutierrez MA, Oikawa H, Oguma T, et al. Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet. 2008;17(6):815\u201324. https:\/\/doi.org\/10.1093\/hmg\/ddm353.","journal-title":"Hum Mol Genet."},{"issue":"10","key":"2355_CR20","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.bbmt.2017.06.020","volume":"23","author":"F Kubaski","year":"2017","unstructured":"Kubaski F, Yabe H, Suzuki Y, Seto T, Hamazaki T, Mason RW, et al. Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis II. Biol Blood Marrow Transplant. 2017;23(10):1795\u2013803. https:\/\/doi.org\/10.1016\/j.bbmt.2017.06.020.","journal-title":"Biol Blood Marrow Transplant."},{"key":"2355_CR21","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/DDDT.S68562","volume":"9","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Sawamoto K, Alm\u00e9ciga-D\u00edaz CJ, Shimada T, Bober MB, Chinen Y, et al. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome. Drug Des Devel Ther. 2015;9:1937\u201353.","journal-title":"Drug Des Devel Ther."},{"issue":"2","key":"2355_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","volume":"117","author":"H Yabe","year":"2016","unstructured":"Yabe H, Tanaka A, Chinen Y, Kato S, Sawamoto K, Yasuda E, et al. Hematopoietic stem cell transplantation for Morquio A syndrome. Mol Genet Metab. 2016;117(2):84\u201394. https:\/\/doi.org\/10.1016\/j.ymgme.2015.09.011.","journal-title":"Mol Genet Metab."},{"key":"2355_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bone.2014.10.014","volume":"70","author":"N Baker","year":"2015","unstructured":"Baker N, Boyette LB, Tuan RS. Characterization of bone marrow-derived mesenchymal stem cells in aging. Bone. 2015;70:37\u201347. https:\/\/doi.org\/10.1016\/j.bone.2014.10.014.","journal-title":"Bone."},{"key":"2355_CR24","doi-asserted-by":"crossref","first-page":"6962801","DOI":"10.1155\/2016\/6962801","volume":"2016","author":"D Medici","year":"2016","unstructured":"Medici D. Endothelial-mesenchymal transition in regenerative medicine. Stem Cells Int. 2016;2016:6962801.","journal-title":"Stem Cells Int."},{"issue":"2","key":"2355_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/107632701300062859","volume":"7","author":"PA Zuk","year":"2001","unstructured":"Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211\u201328. https:\/\/doi.org\/10.1089\/107632701300062859.","journal-title":"Tissue Eng."},{"key":"2355_CR26","doi-asserted-by":"publisher","unstructured":"Fathi E, Farahzadi R. Isolation, culturing, characterization and aging of adipose tissue-derived mesenchymal stem cells: a brief overview. Brazil Arch Biol Technol. 2016;59(0). https:\/\/doi.org\/10.1590\/1678-4324-2016150383.","DOI":"10.1590\/1678-4324-2016150383"},{"issue":"6-7","key":"2355_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejcb.2016.04.003","volume":"95","author":"T Montemurro","year":"2016","unstructured":"Montemurro T, Vigano M, Ragni E, Barilani M, Parazzi V, Boldrin V, et al. Angiogenic and anti-inflammatory properties of mesenchymal stem cells from cord blood: soluble factors and extracellular vesicles for cell regeneration. Eur J Cell Biol. 2016;95(6-7):228\u201338. https:\/\/doi.org\/10.1016\/j.ejcb.2016.04.003.","journal-title":"Eur J Cell Biol."},{"issue":"1","key":"2355_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/cpr.12004","volume":"46","author":"M Rezai Rad","year":"2013","unstructured":"Rezai Rad M, Wise GE, Brooks H, Flanagan MB, Yao S. Activation of proliferation and differentiation of dental follicle stem cells (DFSCs) by heat stress. Cell Prolif. 2013;46(1):58\u201366. https:\/\/doi.org\/10.1111\/cpr.12004.","journal-title":"Cell Prolif."},{"issue":"2","key":"2355_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12420","volume":"51","author":"M Flanagan","year":"2018","unstructured":"Flanagan M, Li C, Dietrich MA, Richard M, Yao S. Downregulation of heat shock protein B8 decreases osteogenic differentiation potential of dental pulp stem cells during in vitro proliferation. Cell Prolif. 2018;51(2):e12420. https:\/\/doi.org\/10.1111\/cpr.12420.","journal-title":"Cell Prolif."},{"issue":"4","key":"2355_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1634\/stemcells.22-4-625","volume":"22","author":"K Bieback","year":"2004","unstructured":"Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22(4):625\u201334. https:\/\/doi.org\/10.1634\/stemcells.22-4-625.","journal-title":"Stem Cells."},{"issue":"1","key":"2355_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12015-014-9545-9","volume":"11","author":"C Akyurekli","year":"2015","unstructured":"Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Reviews. 2015;11(1):150\u201360. https:\/\/doi.org\/10.1007\/s12015-014-9545-9.","journal-title":"Stem Cell Reviews."},{"issue":"1","key":"2355_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/MNH.0b013e328332fb6f","volume":"19","author":"G Camussi","year":"2010","unstructured":"Camussi G, Deregibus MC, Tetta C. Paracrine\/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens. 2010;19(1):7\u201312. https:\/\/doi.org\/10.1097\/MNH.0b013e328332fb6f.","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"2","key":"2355_CR33","first-page":"256","volume":"35","author":"C Harding","year":"1984","unstructured":"Harding C, Heuser J, Stahl P. Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol. 1984;35(2):256\u201363.","journal-title":"Eur J Cell Biol."},{"issue":"3","key":"2355_CR34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1083\/jcb.101.3.942","volume":"101","author":"BT Pan","year":"1985","unstructured":"Pan BT, Teng K, Wu C, Adam M, Johnstone RM. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol. 1985;101(3):942\u20138. https:\/\/doi.org\/10.1083\/jcb.101.3.942.","journal-title":"J Cell Biol."},{"issue":"4","key":"2355_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328. https:\/\/doi.org\/10.1038\/nrm.2017.125.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"2355_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","volume":"207","author":"MJ Haney","year":"2015","unstructured":"Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, et al. Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release. 2015;207:18\u201330. https:\/\/doi.org\/10.1016\/j.jconrel.2015.03.033.","journal-title":"J Control Release."},{"issue":"6","key":"2355_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845\u201354. https:\/\/doi.org\/10.1089\/scd.2012.0395.","journal-title":"Stem Cells Dev."},{"issue":"6","key":"2355_CR38","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.yjmcc.2009.12.021","volume":"48","author":"RC Lai","year":"2010","unstructured":"Lai RC, Arslan F, Tan SS, Tan B, Choo A, Lee MM, et al. Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. J Mol Cell Cardiol. 2010;48(6):1215\u201324. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.12.021.","journal-title":"J Mol Cell Cardiol."},{"key":"2355_CR39","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.201","volume":"1","author":"P Jenjaroenpun","year":"2013","unstructured":"Jenjaroenpun P, Kremenska Y, Nair VM, Kremenskoy M, Joseph B, Kurochkin IV. Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing. PeerJ. 2013;1:e201. https:\/\/doi.org\/10.7717\/peerj.201.","journal-title":"PeerJ."},{"issue":"5","key":"2355_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.biotechadv.2012.08.008","volume":"31","author":"RC Lai","year":"2013","unstructured":"Lai RC, Yeo RW, Tan KH, Lim SK. Exosomes for drug delivery - a novel application for the mesenchymal stem cell. Biotechnol Adv. 2013;31(5):543\u201351. https:\/\/doi.org\/10.1016\/j.biotechadv.2012.08.008.","journal-title":"Biotechnol Adv."},{"issue":"4","key":"2355_CR41","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851\u20138. https:\/\/doi.org\/10.1002\/stem.2575.","journal-title":"Stem Cells."},{"issue":"1","key":"2355_CR42","doi-asserted-by":"publisher","first-page":"17274","DOI":"10.1038\/s41598-019-53844-5","volume":"9","author":"MA Do","year":"2019","unstructured":"Do MA, Levy D, Brown A, Marriott G, Lu B. Targeted delivery of lysosomal enzymes to the endocytic compartment in human cells using engineered extracellular vesicles. Sci Rep. 2019;9(1):17274. https:\/\/doi.org\/10.1038\/s41598-019-53844-5.","journal-title":"Sci Rep."},{"issue":"8","key":"2355_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042840","volume":"7","author":"DM Iglesias","year":"2012","unstructured":"Iglesias DM, El-Kares R, Taranta A, Bellomo F, Emma F, Besouw M, et al. Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro. PLoS One. 2012;7(8):e42840. https:\/\/doi.org\/10.1371\/journal.pone.0042840.","journal-title":"PLoS One."},{"issue":"10","key":"2355_CR44","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/stem.1481","volume":"31","author":"VJ Coulson-Thomas","year":"2013","unstructured":"Coulson-Thomas VJ, Caterson B, Kao WW. Transplantation of human umbilical mesenchymal stem cells cures the corneal defects of mucopolysaccharidosis VII mice. Stem Cells. 2013;31(10):2116\u201326. https:\/\/doi.org\/10.1002\/stem.1481.","journal-title":"Stem Cells."},{"key":"2355_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/5584_2018_219","volume":"1089","author":"CR Harrell","year":"2018","unstructured":"Harrell CR, Simovic Markovic B, Fellabaum C, Arsenijevic A, Djonov V, Arsenijevic N, et al. Therapeutic potential of mesenchymal stem cell-derived exosomes in the treatment of eye diseases. Adv Exp Med Biol. 2018;1089:47\u201357. https:\/\/doi.org\/10.1007\/5584_2018_219.","journal-title":"Adv Exp Med Biol."},{"key":"2355_CR46","doi-asserted-by":"publisher","first-page":"3274054","DOI":"10.1155\/2016\/3274054","volume":"2016","author":"RJ Emnett","year":"2016","unstructured":"Emnett RJ, Kaul A, Babic A, Geiler V, Regan D, Gross G, et al. Evaluation of tissue homogenization to support the generation of GMP-compliant mesenchymal stromal cells from the umbilical cord. Stem Cells Int. 2016;2016:3274054.","journal-title":"Stem Cells Int"},{"key":"2355_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21037\/sci.2019.06.04","volume":"6","author":"N Rajabzadeh","year":"2019","unstructured":"Rajabzadeh N, Fathi E, Farahzadi R. Stem cell-based regenerative medicine. Stem Cell Investig. 2019;6:19. https:\/\/doi.org\/10.21037\/sci.2019.06.04.","journal-title":"Stem Cell Investig."},{"issue":"1","key":"2355_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/0973-6247.59386","volume":"4","author":"P Shetty","year":"2010","unstructured":"Shetty P, Cooper K, Viswanathan C. Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian J Transfus Sci. 2010;4(1):14\u201324. https:\/\/doi.org\/10.4103\/0973-6247.59386.","journal-title":"Asian J Transfus Sci."},{"issue":"1","key":"2355_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13287-021-02222-y","volume":"12","author":"M Mebarki","year":"2021","unstructured":"Mebarki M, Abadie C, Larghero J, Cras A. Human umbilical cord-derived mesenchymal stem\/stromal cells: a promising candidate for the development of advanced therapy medicinal products. Stem Cell Res Ther. 2021;12(1):152. https:\/\/doi.org\/10.1186\/s13287-021-02222-y.","journal-title":"Stem Cell Res Ther."},{"issue":"4","key":"2355_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137. https:\/\/doi.org\/10.1080\/14653240600855905.","journal-title":"Cytotherapy."},{"issue":"2","key":"2355_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0009-8981(90)90339-T","volume":"187","author":"OP van Diggelen","year":"1990","unstructured":"van Diggelen OP, Zhao H, Kleijer WJ, Janse HC, Poorthuis BJ, van Pelt J, et al. A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A). Clin Chim Acta. 1990;187(2):131\u20139. https:\/\/doi.org\/10.1016\/0009-8981(90)90339-T.","journal-title":"Clin Chim Acta."},{"issue":"5","key":"2355_CR52","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s13346-020-00714-7","volume":"10","author":"E Jain","year":"2020","unstructured":"Jain E, Flanagan M, Sheth S, Patel S, Gan Q, Patel B, et al. Biodegradable polyethylene glycol hydrogels for sustained release and enhanced stability of rhGALNS enzyme. Drug Delivery Transl Res. 2020;10(5):1341\u201352. https:\/\/doi.org\/10.1007\/s13346-020-00714-7.","journal-title":"Drug Delivery Transl Res"},{"issue":"2","key":"2355_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190744","volume":"13","author":"MM Pleumeekers","year":"2018","unstructured":"Pleumeekers MM, Nimeskern L, Koevoet JLM, Karperien M, Stok KS, van Osch G. Trophic effects of adipose-tissue-derived and bone-marrow-derived mesenchymal stem cells enhance cartilage generation by chondrocytes in co-culture. PloS one. 2018;13(2):e0190744. https:\/\/doi.org\/10.1371\/journal.pone.0190744.","journal-title":"PloS one."},{"issue":"3","key":"2355_CR54","doi-asserted-by":"publisher","first-page":"789","DOI":"10.7150\/thno.18133","volume":"7","author":"P Li","year":"2017","unstructured":"Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789\u2013804. https:\/\/doi.org\/10.7150\/thno.18133.","journal-title":"Theranostics."},{"issue":"7","key":"2355_CR55","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671\u20135. https:\/\/doi.org\/10.1038\/nmeth.2089.","journal-title":"Nat Methods."},{"issue":"9","key":"2355_CR56","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4103\/1947-2714.100998","volume":"4","author":"T Mahmood","year":"2012","unstructured":"Mahmood T, Yang PC. Western blot: technique, theory, and trouble shooting. N Am J Med Sci. 2012;4(9):429\u201334. https:\/\/doi.org\/10.4103\/1947-2714.100998.","journal-title":"N Am J Med Sci."},{"issue":"22","key":"2355_CR57","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1093\/hmg\/ddi364","volume":"14","author":"S Tomatsu","year":"2005","unstructured":"Tomatsu S, Gutierrez M, Nishioka T, Yamada M, Yamada M, Tosaka Y, et al. Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase. Human molecular genetics. 2005;14(22):3321\u201335. https:\/\/doi.org\/10.1093\/hmg\/ddi364.","journal-title":"Human molecular genetics."},{"key":"2355_CR58","doi-asserted-by":"publisher","first-page":"6869128","DOI":"10.1155\/2018\/6869128","volume":"2018","author":"N Yusop","year":"2018","unstructured":"Yusop N, Battersby P, Alraies A, Sloan AJ, Moseley R, Waddington RJ. Isolation and characterisation of mesenchymal stem cells from rat bone marrow and the endosteal niche: a comparative study. Stem Cells Int. 2018;2018:6869128.","journal-title":"Stem Cells Int"},{"issue":"21","key":"2355_CR59","doi-asserted-by":"publisher","first-page":"12115","DOI":"10.1016\/S0021-9258(18)63825-6","volume":"264","author":"NM Dahms","year":"1989","unstructured":"Dahms NM, Lobel P, Kornfeld S. Mannose 6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem. 1989;264(21):12115\u20138. https:\/\/doi.org\/10.1016\/S0021-9258(18)63825-6.","journal-title":"J Biol Chem."},{"issue":"5","key":"2355_CR60","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem cells. 2006;24(5):1294\u2013301. https:\/\/doi.org\/10.1634\/stemcells.2005-0342.","journal-title":"Stem cells."},{"key":"2355_CR61","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3389\/fimmu.2017.01245","volume":"8","author":"MJE Marshall","year":"2017","unstructured":"Marshall MJE, Stopforth RJ, Cragg MS. Therapeutic antibodies: what have we learnt from targeting CD20 and where are we going? Front Immunol. 2017;8:1245. https:\/\/doi.org\/10.3389\/fimmu.2017.01245.","journal-title":"Front Immunol."},{"issue":"3","key":"2355_CR62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1385\/JMN:11:3:223","volume":"11","author":"MZ Jones","year":"1998","unstructured":"Jones MZ, Brumfield LK, King BM, Hopwood JJ, Byers S. Recombinant caprine 3H-[N-acetylglucosamine-6-sulfatase] and human 3H-[N-acetylgalactosamine-4-sulfatase]: plasma clearance, tissue distribution, and cellular uptake in the rat. J Mol Neurosci. 1998;11(3):223\u201332. https:\/\/doi.org\/10.1385\/JMN:11:3:223.","journal-title":"J Mol Neurosci."},{"issue":"8","key":"2355_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012194","volume":"5","author":"M Dvorak-Ewell","year":"2010","unstructured":"Dvorak-Ewell M, Wendt D, Hague C, Christianson T, Koppaka V, Crippen D, et al. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice. PloS one. 2010;5(8):e12194. https:\/\/doi.org\/10.1371\/journal.pone.0012194.","journal-title":"PloS one."},{"issue":"6520","key":"2355_CR64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/374367a0","volume":"374","author":"EY Snyder","year":"1995","unstructured":"Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature. 1995;374(6520):367\u201370. https:\/\/doi.org\/10.1038\/374367a0.","journal-title":"Nature."},{"issue":"4","key":"2355_CR65","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s13311-011-0067-8","volume":"8","author":"LS Shihabuddin","year":"2011","unstructured":"Shihabuddin LS, Cheng SH. Neural stem cell transplantation as a therapeutic approach for treating lysosomal storage diseases. Neurotherapeutics. 2011;8(4):659\u201367. https:\/\/doi.org\/10.1007\/s13311-011-0067-8.","journal-title":"Neurotherapeutics."},{"issue":"16","key":"2355_CR66","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.7150\/thno.46332","volume":"10","author":"D Jiang","year":"2020","unstructured":"Jiang D, Chen FX, Zhou H, Lu YY, Tan H, Yu SJ, et al. Bioenergetic crosstalk between mesenchymal stem cells and various ocular cells through the intercellular trafficking of mitochondria. Theranostics. 2020;10(16):7260\u201372. https:\/\/doi.org\/10.7150\/thno.46332.","journal-title":"Theranostics."},{"issue":"7","key":"2355_CR67","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/cdd.2014.211","volume":"22","author":"X Wang","year":"2015","unstructured":"Wang X, Gerdes HH. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ. 2015;22(7):1181\u201391. https:\/\/doi.org\/10.1038\/cdd.2014.211.","journal-title":"Cell Death Differ."},{"issue":"5","key":"2355_CR68","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18(5):759\u201365. https:\/\/doi.org\/10.1038\/nm.2736.","journal-title":"Nat Med."},{"issue":"1","key":"2355_CR69","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/stem.1835","volume":"33","author":"S Naphade","year":"2015","unstructured":"Naphade S, Sharma J, Gaide Chevronnay HP, Shook MA, Yeagy BA, Rocca CJ, et al. Brief reports: Lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes. Stem Cells. 2015;33(1):301\u20139. https:\/\/doi.org\/10.1002\/stem.1835.","journal-title":"Stem Cells."},{"issue":"3","key":"2355_CR70","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/stem.2541","volume":"35","author":"Y Jaimes","year":"2017","unstructured":"Jaimes Y, Naaldijk Y, Wenk K, Leovsky C, Emmrich F. Mesenchymal stem cell-derived microvesicles modulate lipopolysaccharides-induced inflammatory responses to microglia cells. Stem Cells. 2017;35(3):812\u201323. https:\/\/doi.org\/10.1002\/stem.2541.","journal-title":"Stem Cells."},{"issue":"1","key":"2355_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000489739","volume":"47","author":"M Tofino-Vian","year":"2018","unstructured":"Tofino-Vian M, Guillen MI, Perez Del Caz MD, Silvestre A, Alcaraz MJ. Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes. Cell Physiol Biochem. 2018;47(1):11\u201325. https:\/\/doi.org\/10.1159\/000489739.","journal-title":"Cell Physiol Biochem."},{"key":"2355_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fncel.2018.00317","volume":"12","author":"EE Reza-Zaldivar","year":"2018","unstructured":"Reza-Zaldivar EE, Hernandez-Sapiens MA, Minjarez B, Gutierrez-Mercado YK, Marquez-Aguirre AL, Canales-Aguirre AA. Potential effects of MSC-derived exosomes in neuroplasticity in Alzheimer\u2019s disease. Front Cell Neurosci. 2018;12:317. https:\/\/doi.org\/10.3389\/fncel.2018.00317.","journal-title":"Front Cell Neurosci."},{"issue":"6","key":"2355_CR73","doi-asserted-by":"publisher","DOI":"10.4161\/cib.26631","volume":"6","author":"G Maguire","year":"2013","unstructured":"Maguire G. Stem cell therapy without the cells. Commun Integr Biol. 2013;6(6):e26631. https:\/\/doi.org\/10.4161\/cib.26631.","journal-title":"Commun Integr Biol."},{"issue":"5","key":"2355_CR74","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98(5):1076\u201384. https:\/\/doi.org\/10.1002\/jcb.20886.","journal-title":"J Cell Biochem."},{"issue":"7","key":"2355_CR75","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1182\/blood-2007-03-078709","volume":"110","author":"MC Deregibus","year":"2007","unstructured":"Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007;110(7):2440\u20138. https:\/\/doi.org\/10.1182\/blood-2007-03-078709.","journal-title":"Blood."},{"issue":"1","key":"2355_CR76","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/nar\/gkp857","volume":"38","author":"TS Chen","year":"2010","unstructured":"Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 2010;38(1):215\u201324. https:\/\/doi.org\/10.1093\/nar\/gkp857.","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"2355_CR77","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/21541248.2016.1215283","volume":"8","author":"C Tricarico","year":"2017","unstructured":"Tricarico C, Clancy J, D'Souza-Schorey C. Biology and biogenesis of shed microvesicles. Small GTPases. 2017;8(4):220\u201332. https:\/\/doi.org\/10.1080\/21541248.2016.1215283.","journal-title":"Small GTPases."},{"issue":"4","key":"2355_CR78","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1172\/JCI81129","volume":"126","author":"R Xu","year":"2016","unstructured":"Xu R, Greening DW, Zhu HJ, Takahashi N, Simpson RJ. Extracellular vesicle isolation and characterization: toward clinical application. J Clin Invest. 2016;126(4):1152\u201362. https:\/\/doi.org\/10.1172\/JCI81129.","journal-title":"J Clin Invest."},{"key":"2355_CR79","doi-asserted-by":"publisher","unstructured":"Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3(1). https:\/\/doi.org\/10.3402\/jev.v3.24641.","DOI":"10.3402\/jev.v3.24641"},{"issue":"7","key":"2355_CR80","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ncb2502","volume":"14","author":"MF Baietti","year":"2012","unstructured":"Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14(7):677\u201385. https:\/\/doi.org\/10.1038\/ncb2502.","journal-title":"Nat Cell Biol."},{"issue":"1","key":"2355_CR81","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ncb1342","volume":"8","author":"OO Glebov","year":"2006","unstructured":"Glebov OO, Bright NA, Nichols BJ. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol. 2006;8(1):46\u201354. https:\/\/doi.org\/10.1038\/ncb1342.","journal-title":"Nat Cell Biol."},{"issue":"5","key":"2355_CR82","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1600-0854.2010.01041.x","volume":"11","author":"D Feng","year":"2010","unstructured":"Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 2010;11(5):675\u201387. https:\/\/doi.org\/10.1111\/j.1600-0854.2010.01041.x.","journal-title":"Traffic."},{"issue":"3","key":"2355_CR83","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2011-02-338004","volume":"119","author":"A Montecalvo","year":"2012","unstructured":"Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood. 2012;119(3):756\u201366. https:\/\/doi.org\/10.1182\/blood-2011-02-338004.","journal-title":"Blood."},{"issue":"4","key":"2355_CR84","doi-asserted-by":"publisher","first-page":"19005","DOI":"10.4238\/2015.December.29.8","volume":"14","author":"JP Li","year":"2015","unstructured":"Li JP, Wang DW, Song QH. Transplantation of erythropoietin gene-transfected umbilical cord mesenchymal stem cells as a treatment for limb ischemia in rats. Genet Mol Res. 2015;14(4):19005\u201315. https:\/\/doi.org\/10.4238\/2015.December.29.8.","journal-title":"Genet Mol Res."},{"issue":"3","key":"2355_CR85","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10529-018-2505-8","volume":"40","author":"TG de Carvalho","year":"2018","unstructured":"de Carvalho TG, Pellenz FM, Laureano A, da Rocha Silla LM, Giugliani R, Baldo G, et al. A simple protocol for transfecting human mesenchymal stem cells. Biotechnol Lett. 2018;40(3):617\u201322. https:\/\/doi.org\/10.1007\/s10529-018-2505-8.","journal-title":"Biotechnol Lett."},{"key":"2355_CR86","doi-asserted-by":"publisher","first-page":"735349","DOI":"10.1155\/2010\/735349","volume":"2010","author":"C Madeira","year":"2010","unstructured":"Madeira C, Mendes RD, Ribeiro SC, Boura JS, Aires-Barros MR, da Silva CL, et al. Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy. J Biomed Biotechnol. 2010;2010:735349.","journal-title":"J Biomed Biotechnol."},{"issue":"11","key":"2355_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801271","volume":"8","author":"MJ Haney","year":"2019","unstructured":"Haney MJ, Klyachko NL, Harrison EB, Zhao Y, Kabanov AV, Batrakova EV. TPP1 delivery to lysosomes with extracellular vesicles and their enhanced brain distribution in the animal model of batten disease. Adv Healthc Mater. 2019;8(11):e1801271.","journal-title":"Adv Healthc Mater."},{"issue":"1","key":"2355_CR88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2121-7-14","volume":"7","author":"MM Bonab","year":"2006","unstructured":"Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006;7(1):14. https:\/\/doi.org\/10.1186\/1471-2121-7-14.","journal-title":"BMC Cell Biol."},{"issue":"2","key":"2355_CR89","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/jcp.20376","volume":"205","author":"V Vacanti","year":"2005","unstructured":"Vacanti V, Kong E, Suzuki G, Sato K, Canty JM, Lee T. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol. 2005;205(2):194\u2013201. https:\/\/doi.org\/10.1002\/jcp.20376.","journal-title":"J Cell Physiol."},{"issue":"7","key":"2355_CR90","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/154405910808700716","volume":"87","author":"T Takeda","year":"2008","unstructured":"Takeda T, Tezuka Y, Horiuchi M, Hosono K, Iida K, Hatakeyama D, et al. Characterization of dental pulp stem cells of human tooth germs. J Dent Res. 2008;87(7):676\u201381. https:\/\/doi.org\/10.1177\/154405910808700716.","journal-title":"J Dent Res."},{"issue":"1","key":"2355_CR91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12015-010-9168-8","volume":"7","author":"CG Fan","year":"2011","unstructured":"Fan CG, Zhang QJ, Zhou JR. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev Rep. 2011;7(1):195\u2013207. https:\/\/doi.org\/10.1007\/s12015-010-9168-8.","journal-title":"Stem Cell Rev Rep."},{"issue":"8","key":"2355_CR92","first-page":"1017","volume":"91","author":"LL Lu","year":"2006","unstructured":"Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91(8):1017\u201326.","journal-title":"Haematologica."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02355-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T03:41:33Z","timestamp":1724989293000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02355-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2355"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02355-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"25 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Morquio A fibroblasts were obtained from a de-identified repository located at Saint Louis University. The Institutional Review Board (IRB) at Saint Louis University determined that our human subjects research was exempt from a formal IRB submission due to lack of patient identifiers or protected health information (PHI).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}